LBDA’s 2025 Community Webinar Series

Knowledge is Power

Presented by expert clinicians, these webinars help the LBD community learn more about the complexity of the disease and better manage its symptoms.

Empower Your Journey

These webinars feature strategies for self-advocacy and ways that the LBD community can access services and support to live well with Lewy.

Toolbox Talks

These webinars offer tips, techniques and activities designed to enhance quality of life for those with LBD and their care partners.

View webinars

Visit our YouTube channel LBDAtv, to watch new and previous webinars.

Watch Now

Join our email list

Stay up-to-date on the latest LBD news and LBDA events!

NEXT WEBINAR

Seeing the Way: Enhancing Life with Lewy Body Dementia through Visual Strategies

Tuesday, February 18, 2025, 2-3:00pm EST

Lewy body dementia (LBD) can affect the brain’s ability to process visual information correctly, leading to difficulties with depth perception and spatial awareness. This can increase the risk of falls and make navigation around the home or in unfamiliar environments more difficult. Visual impairments associated with LBD can also affect the ability to perform daily activities, such as dressing, cooking, and driving. This can lead to a loss of independence and increased reliance on caregivers.

This webinar will address these visual challenges.

UPCOMING WEBINAR

Clinical Trial Results: What We Learned from Recent Phase 2 Trials in DLB

Thursday, March 20, 2025, 2-3:00pm EDT

In the last 6 months, three Phase 2 clinical trials for investigational drugs in dementia with Lewy bodies (DLB) have reported results. These include interim results from a small study of nilotinib, and topline results from trials of neflamapimod and CT1812 – the RewinD-LB and SHIMMER trials, respectively.

In “Clinical Trial Results: What We Learned from Recent Phase 2 Trials in DLB,” Dr. James E. Galvin, the primary study lead for the RewinD-LB and SHIMMER trials will share the results of these trials and answer your questions. Keith Fargo, Ph.D., Director of Scientific Initiatives for the Lewy Body Dementia Association, will tell you about a few planned LBD trials and how to receive more information about them.